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The chest wall refers to the structures 
surrounding and protecting the lungs, enclosed by 
the spine, and separated from the abdominal 
cavity by the diaphragm. These structures include 
multiple tissue types, including cartilage, bone, 
muscle, fascia, vasculature, lymphatic vessels, fat, 
and skin [1]. Chest wall tumors could be 
subdivided into two main categories, primary and 
secondary. Primary chest wall tumors arise from 
muscle, fat, blood vessel, nerve sheath, cartilage, 
or bone of the chest wall. On the other hand, the 
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Abstract 
Background: Chest wall resection and further reconstruction for tumors represent a 
challenging concept for surgeons. Thanks to the evolving reconstruction techniques, 
good results were obtained after extensive resection and reconstruction. 
Methods: This prospective cohort study was conducted at our University Hospitals 
throughout 5 years. A total of 43 eligible cases with chest wall tumors were included. 
All cases were subjected to a multidisciplinary team approach, complete history 
taking, physical examination, radiological evaluation, and biopsy. The details of 
surgical techniques, complications, and follow up parameters were included. 
Results: The mean age of the included cases was 29.45 years. We included a total of 
24 males (55.8%). Fibromatosis was the commonest encountered pathology (27.9%), 
followed by chondrosarcoma (25.5%), and osteosarcoma (21%). Regarding the 
method of reconstruction, polypropylene mesh was used in 46.5% of cases, followed 
by direct closure (30.2%). Ten cases were managed by Methyl Methacrylate within 
the proline mesh (23.3%), while superimposed muscle flap was performed in only 2 
cases (4.6%). Post-operatively, bleeding was encountered in 5 cases collectively 
(11.6%), while wound infection occurred in 11.6% of cases. Pulmonary complications 
included pneumonia (2.3%) and atelectasis (11.6%). Furthermore, chest wall 
instability was present in (11.6%) of cases. On follow up, recurrence was diagnosed 
in (9.3%) of cases (n = 4). 
Conclusion: Surgical intervention is very effective if tailored to every patient as per 
team plan. A multidisciplinary team approach is extremely important especially if an 
extensive demolition is required. Indeed, radical wide en-bloc resection can achieve 
satisfactory results provided that the extent of resection is not influenced by any 
anticipated reconstruction problems. 
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secondary can be from direct invasion of breast or 
lung cancer or metastases from a distant 
malignant tumor. Of note, the chest wall can be 
also involved by primary pleural malignancies [2]. 
Primary chest wall tumors are rare (0.04% of 
all body new tumors, and 5% of thoracic 
neoplasms). About 50 percent of these tumors 
are malignant [3]. Nowadays, the exact etiology 
of these tumors is not yet defined. However, 
genetics, lifestyle, and diet may play a role [4]. 
Extra-abdominal desmoid tumors can arise at the 
site of previous thoracotomy [5].  
Resection of these tumors could be 
challenging for either thoracic or reconstructive 
surgeons, as it can lead to postoperative 
pulmonary dysfunction. Therefore, it is 
recommended to use a multidisciplinary approach 
when managing such lesions to optimized post-
surgical outcomes [6, 7]. 
After tumor excision, it is crucial to establish a 
functional framework for chest wall 
reconstruction. After that, it should be covered 
with healthy well-vascularized tissue. Generally, 
prosthetic materials along with soft tissue flaps 
are used for coverage to maintain skeletal 
stability. Although soft tissue coverage can be 
performed via rotational skin and muscle flaps, 
complex reconstructions may be also needed in 
some cases [8]. 
Post-surgical outcomes are usually related to 
the type of tumor excised, and the extent of 
resection [9, 10]. In this study, we present our 
experience with chest wall tumor resections in our 
university hospital. Our referral center covers a 
great sector of the eastern part of the country.  
Patients and Methods: 
Study design and setting: 
This is a prospective cohort study that was 
conducted over 5 years (from January 2015 till 
January 2020) on patients presented with chest 
wall tumors presented to Mansoura University 
hospitals. The outpatient clinics of our 
departments serve patients from 4 neighboring 
governorates in eastern Egypt (Dakahila, 
Damietta, Port Said, and Kafr Elsheikh) with an 
average of 3280 patients per year at the time of 
the study. 
Inclusion and exclusion criteria: 
Although there was no age or gender 
limitation for participating in the current study, 
refusal to participate, or unfitness for general 
anesthesia were causes of exclusion. We excluded 
cases of elastofibromas as they are benign soft-
tissue pseudotumor and lipomas which were 
usually excised with no need for chest wall 
reconstruction. The invasion of the chest wall by 
bronchogenic carcinomas was excluded.
Figure 1: (A) Cranio-caudal view showing a Female patient with a protruding sternal mass. (B) Right side (surgeon’s) 
view of a protruding sternal tumor in a female patient.
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Figure 2: High resolution Computed tomography of the chest wall with three-dimensional reconstruction showing a 
right-sided chest wall mass occupying the right seventh rib anteriorly.
Ethical considerations and consent to participate: 
Informed written consent was obtained from 
all cases after the explanation of the details and 
possible drawbacks of the surgical intervention. 
Moreover, the study was approved by the 
Institutional research board (approval number 
MUIRB-651-15). All patients signed written 
consent for publishing the medical data without 
identity disclosure. 
Surgical workup and approach: 
All cases presented or were referred to our 
outpatient clinics were subjected to a 
multidisciplinary team (MDT) approach by 
performing regular Pulmonology- thoracic surgery 
– oncology – cardiothoracic anesthesia meetings
to determine tailored patient treatment plans and 
to perform updated briefing on postoperative 
patient status.  
Based on the imaging findings and pathological 
diagnosis, an MDT decision was taken for all cases. 
All cases were subjected to complete history 
taking, thorough physical examination (Figure 1: 
A, B), and routine preoperative laboratory 
investigations. Besides, radiological investigations 
including chest X-ray, Computed tomography (CT), 
and/or Magnetic resonance imaging (MRI) were 
ordered to assess the degree of tumor extension 
(Figure 2). Pulmonary function tests (PFT’s) were 
done for selected patients if there was dyspnea or 
the expected chest wall resection was extensive. 
Comparing preoperative and postoperative PFT’s 
was out of the scope of this study. A biopsy was 
also ordered for most cases to confirm the 
diagnosis. 
In all malignant tumors, a metastatic workup 
was ordered preoperatively.  And all cases were 
also assessed by the anesthetic team before the 
procedure. Following tailored surgical planning, all 
cases underwent surgery with a curative goal after 
tailored surgical planning. Wide en-bloc radical 
excision was performed with keeping 
circumferential radical margins of at least 4–5 cm 
putting into consideration the nature of the
Sanad M 
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Figure 3: A STROBE flow-chart of the study indicating the recruitment of participants
pathology. Aggressive tumors and those with high 
recurrence rates; as fibromatosis; required more 
bony and soft tissue safety margins.  
A chest tube was inserted into the thoracic 
cavity then after reconstruction a wound drain 
was inserted. As regard anesthesia, a single-lumen 
endotracheal tube was sufficient, thoracic 
epidural analgesia was a must as there was 
predicted severe postoperative pain.  
According to the size, pathology of the 
neoplasm, and nature of the defect, multiple 
options were available for reconstruction after 
tumor excision, including polypropylene mesh, 
Methyl Methacrylate sandwiched between two 
layers of the mesh or muscle flaps. 
The choice of the suitable material and 
method of chest wall reconstruction was at the 
discretion of the operating surgeon based on the 
experience and familiarity with the chosen 
technique. We considered reconstruction for large 
defects that required resection of 3 or more ribs.  
Small defects and apicoposterior defects do 
not require reconstruction as the later are 
protected by the scapula and shoulder girdle. 
Defects lower than 4th rib posteriorly are at the 
risk of entrapment of the tip of the scapula.   
Postoperative management: 
After the operation, the cases were 
transferred to the intermediate care unit, and 
then to the ward unless complications were 
anticipated. Patients who have multiple 
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comorbidities were transferred to the intensive 
care unit (ICU). Early ambulation and chest 
physiotherapy were encouraged. Pain control was 
achieved using Epidural analgesia in the first 3 
days postoperatively. After removal of the 
epiduaral catheter, NSAIDs and opioids were given 
accordingly until the patient is discharged. 
Postoperative lung function was not tested 
and this outcome was not tested in this study. All 
cases were reviewed for the need for 
postoperative adjuvant therapy. At the regular 
follow up visits at 1 week, one month, three 
months, six months, one year, two years, three 
years following discharge, cases were assessed 
clinically and radiologically for the outcome of 
resection. All patients Completed a minimum 
follow up 13 months and a maximum of three 
years of some patients. Moreover, if complications 
were encountered, they were recorded and 
managed via a MDT approach. 
Definitions of study outcomes: 
Large defects were defined as defects that need 
resection of 3 or more ribs. 
Significant bleeding was defined as persistent 
bleeding and large volumes concerning the 
patients’ body surface area (4ml/kg/hour or more) 
or bleeding that results in a progressive drop in 
hemodynamics or patients’ hemoglobin that may 
necessitate a blood transfusion. 
Insignificant bleeding was defined as the bleeding 
that had a regressive course, it did not affect 
hemodynamics and responded to coagulants.  
Chest wall instability was defined as an obvious 
paradoxical movement of the chest wall defect 
after the repair when upon breathing 
spontaneously.  
Superficial wound infection was defined as 
surgical wound discharge accompanied by at least 
one of the local signs and symptoms of infection 
like pain, tenderness, localized swelling, or 
redness.  
Deep wound infection was defined as wound 
disruption and systemic signs and symptoms of 
sepsis.  
Milk fistula was defined as a rare condition that 
occurs when there is an abnormal connection that 
forms between the skin surface and the duct in the 
breast of a lactating woman, resulting in 
spontaneous and often constant drainage of milk 
from this path of least resistance. It might be a 
complication that results from a needle biopsy or 
surgical intervention in a lactating patient. 
Study endpoints: 
The primary endpoint was the presentation of 
the histopathological type of the resected 
specimens in our sample. The secondary 
endpoints were the clinical presentation of the 
patients, the laterality, surgical access, method of 
chest wall reconstruction, and postprocedural 
morbidity and mortality. 
Statistical analysis: 
A total of 43 eligible patients were enrolled. 
The data were tabulated and analyzed using IBM 
SPSS software version 22.0 (IBM Inc., Chicago, IL, 
USA). Qualitative data were described using the 
number and percent. Continuous quantitative 
variables were assessed for normality; normally 
distributed variables were reported as mean and 
standard deviation (SD). Skewed variables were 
reported as median and interquartile range. 
Results 
A STROBE flow-chart of participants is 
presented in (Figure 3), indicating the sequential 
recruitment of individuals. Eligible were 43 
consecutive patients with a mean age of 
29.45±4.62 years. We included a total of 24 males 
(55.8%) as well as 19 females (44.2%). One case 
had a previous history of trauma (2.3%). 
Moreover, previous chest surgery was performed 
in 1 case (2.3%). 
Regarding the presenting symptoms, the pain 
was the most common presentation (28 cases – 
65.1%). Other presentations and patient 
characteristics are shown in (Table 1). The most 
common affected chest wall side was the right one 
(51.2%), followed by the left side (41.9%), two  
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Table 1: Demographic data and presenting symptoms 
of 43 cases with chest wall tumors 
Patients (n= 43) 
n (%) 
Age 29.45 ± 18.868 
Gender 
Male 55.8% (24) 
Female 44.2% (19) 
Comorbidities 
Smoking 14 (32.6) 
Trauma 1 (2.3) 
Previous chest operation 1 (2.3) 
DM 9 (20.9) 
HTN 4 (9.3) 
Asthma 3 (7) 
Presenting symptoms 
Pain 28 (65.1) 
Mass 27 (62.8) 
Tenderness 4 (9.3) 
Discharging ulcer 1 (2.3) 
Dyspnea 5 (11.6) 
DM: Diabetes Mellitus; HTN: Hypertension 
cases had a sternal tumor (4.65%) and one patient 
(2.3) had right-sided chondrosarcoma of the 2nd, 
3rd, 4th, ribs and the adjoining left hemisternum 
(Table 2).  
Rib destruction was detected in 20.9% of 
cases, while calcifications were present in 41.9% 
of patients proved by the multi-slice CT chest 
reconstruction (Figure 2). 
Trucut biopsy was the commonest modality 
(76.7%), followed by incisional biopsy (16.3%), and 
lastly excisional biopsy for 3 cases (7%). A fine 
needle biopsy was not suitable for hard bony 
tumors.  
Strangely Fibromatosis (desmoid tumor) was 
the commonest pathology (27.9%) in our series 
(Figure 4), followed by chondrosarcoma (25.6%) 
and osteosarcoma (21%). Another pathological 
spectrum is shown in (Table 2). 
Video-assisted thoracoscopic surgery (VATS) 
hybrid approach was used in 2 cases (4.7%). In one 
patient with a pedicled tumor attached to the 6th 
rib, it helped to determine the exact site of the 
tumor. Also, in another young male patient with  
Table 2: Radiological findings, type of biopsy and 












Right 22 (51.2) 
Left 18 (41.9) 
sternum 2 (4.6) 
combined 1 (2.3) 
Effect 
osteolytic 9 (20.9) 
calcification 18 (41.9) 
Protrusion 
(mainly) 
Outward 7 (16.3) 
Inward 16 (37.2) 
Both sides 20 (46.5) 
Biopsy 
Excisional 3 (7) 
Incisional 7 (16.3) 
Trucut 33 (76.7) 
Pathology 
Fibromatosis 12 (27.9) 
Chondroma 4 (9.3) 
Chondrosarcoma 11 (25.5) 
osteosarcoma 9 (21) 
Ewing sarcoma 1 (2.3) 
Fibrous dysplasia 1 (2.3) 
osteoma 2 (4.6) 
Spindle cell tumor 1 (2.3) 
Metastasis 2 (4.6) 
huge metastasis from a previously excised left leg 
osteosarcoma which was occupying the left 
costomediastinal recess with significant 
mediastinal shift and doubtful invasion of the 
diaphragm and pericardium. Preliminary VATS 
helped us to dissect the tumor and align exactly 
the tumor borders with adequate safety margins.  
The resulting defect after tumor excision was large 
(3 ribs or more) in 74.4% of cases (32 patients) 
which were evaluated for the suitable method of 
reconstruction. The average defect span was 
3.8±2.5 ribs (ranging from 1 rib to 7 ribs). 
Thirty-two cases required skeletal chest wall 
reconstruction. Prolene mesh was used in 46.5% 
of cases, while Methyl Methacrylate sandwiched 
between two layers of polypropylene mesh was 
used in (23.25%) (Figure 5: A, B, C). Superimposed 
muscle flaps were used in 2 cases. Thirteen cases 
(30.2%) needed no construction due to small 
defects (11 cases) or anatomically protected 
defects (2 cases). 
The Egyptian Cardiothoracic Surgeon 
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VATS approach 2 (4.7) 
Defect size 
small 11 (25.6) 
Large ≥3 ribs 32 (74.4) 
Reconstruction 
method 
None 13 (30.2) 
Bone cement & 
Prolene mesh 
10 (23.3) 
Muscle flap 2 (4.6) 
Prolene mesh 20 (46.5) 
Complications 
Recurrence 4 (9.3) 
Chest wall instability 5 (11.6) 
Wound discharge 4 (9.3) 
Bleeding and exploration 1 (2.3) 
Bleeding no exploration 4 (9.3) 
Milk fistula 1 (2.3) 
Pneumonia 1 (2.3) 
Atelectasis 5 (11.6) 
Mortality 0 
Postoperative bleeding was encountered in 
one patient in our series who required re-
exploration due to significant bleeding had no 
chest wall reconstruction and the source was an 
intercostal artery. 
Four cases had higher bloody drainage in the 
first postoperative day which was controlled 
medically. Another 4 cases showed superficial 
wound infection. Proper antibiotics and frequent 
dressing were sufficient. In a female patient 24 
years old with excised right 3rd and 4th ribs 
anteriorly due to chondrosarcoma was proved to 
have a milk fistula that managed medically well. 
The medical management included broad-
spectrum antibiotic treatment till modified by a 
culture result and cabergoline (prolactin 
antagonist) without breast pumping was 
prescribed by a general surgeon to slow milk 
production and drainage, and thus promote 
wound healing. Simple local wound care with 
Vaseline gauze was used to help with healing.  
Five patients who received large 
polypropylene mesh, chest wall paradoxical 
movement was evident while spontaneous 
breathing during weaning of anesthesia. Heavy 
dressing with a wide adhesive bandage for few 
days was enough to stabilize the chest.     
Most patients had epidural analgesia for the first 
postoperative day. NSAID and opioids were given 
latter according to the degrees of pain. All 
postoperative complications are illustrated in 
(Table 3).
Figure 4: Desmoid tumor invading the anterior chest wall of a 64 years old male patient. A. Inspection of the anterior 
chest wall mass B. Computed tomography of the chest showing the mass. C. the specimen after wide local excision.
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Figure 5: A. The first step in constricting chest wall by bone cement sandwich. Closing the defect by 1st layer proline 
mesh from 3 sides leaving one for helping protection of the underlying structures.  B. Applying the Methyl 
Methacrylate film over the proline mesh. C. final view of the bone cement sandwich and drain in situ
Discussion 
This study was conducted at our 
cardiothoracic surgery department in a university 
hospital aiming to present our experience in chest 
wall tumor resection and reconstruction. 
The mean age of our series was 29.45 years 
ranging from 6 to 65 years old.  According to the 
previous literature, there is a great variation in the 
age of presentation almost like our series. 
Nevertheless, younger patients have smaller and 
more benign tumors, whereas older patients tend 
to have larger and more aggressive tumors [11]. 
In our study, we have a total of 24 males in 
addition to 19 females. And this result copes with 
other researches who showed the frequency of 
chest wall tumors is more common in males [12]. 
The presentation in our study including pain 
(65.1%), mass (62.8%), tenderness (9.3), dyspnea 
(14%), and discharging ulcer (2.3%). While chest 
wall neoplasms can be asymptomatic and 20% of 
them detected incidentally on chest X-ray [13, 14]. 
In the current study, our cases were evaluated 
initially by chest X-ray, and CT or MRI was 
subsequently ordered. Although the chest X-ray 
can detect cortical bone destruction or confirm 
the tumor of bony origin; CT is more sensitive in 
evaluating all the mentioned parameters and also 
evaluating the lung and the pleural invasion by 
the tumor [15]. Moreover, MRI can help to 
differentiate neoplastic lesions from other 
mimicking disorders like inflammation or 
infection, it can demonstrate the various internal 
components of complex lesions and also the 
neurological and vascular invasion of the tumor 
[16].  
In our study, a biopsy was ordered nearly for 
all cases. Trucut biopsy was the gold standard 
technique (76.7%) being safe and sufficient, 
followed by incisional one (16.3%) and lastly the 
excisional one (7%). Other biopsy types included 
fine needle looks inappropriate. 
It is usually recommended to take a biopsy 
from such lesions as the radiological diagnosis is 
usually inadequate for definitive diagnosis. It is 
recommended to take an excisional biopsy for 
lesions less than 5 cm in size. For larger lesions, 
incisional biopsy or true cut needle biopsy can be 
performed [14]. 
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After the biopsy, the delay is not permitted, 
and the surgery must be done rapidly taking into 
consideration the excision of the biopsy track 
together with skin ellipse. Regarding tumor types 
encountered in the current study, fibromatosis 
was the commonest encountered pathology 
(27.9%), followed by chondrosarcoma (25.5%), 
and osteochondroma (21%). 
Desmoid tumors (also called aggressive 
fibromatosis) are benign myofibroblastic 
neoplasms. They are rare tumors. In 8–10% of 
cases, their location is in the chest wall. When 
chest involvement is present, these are known to 
be locally aggressive with a high recurrence rate 
[17].  
A previous study has also published that 
chondrosarcoma is the commonest chest wall 
malignancy, as it accounts for 30% of the primary 
malignancies [18]. 
There is no explanation of why the prevalence 
of fibromatosis was high in the last few years. In 
our study, it affects mainly middle-aged females 
and has a high degree of recurrence.    
Chest wall surgery is the best option for the 
primary tumors and also for selected cases of 
secondary tumors which may be a curative option 
[7, 19]. Wide tumor excision with negative 
margins is a critical predictor of local recurrence 
rates. It is also imperative that following resection, 
there is a chest wall stabilization to avoid a 
negative impact on respiratory function [20, 21]. 
Rigid reconstructive techniques depending on 
autologous rib grafts or semirigid fascial grafts are 
less commonly used since the introduction of 
synthetic mesh as in our study. The ideal synthetic 
mesh should be rigid enough to minimize 
paradoxical chest wall movement, porous enough 
to allow tissue ingrowth, malleable, radiolucent 
(i.e. to see any radiographic evidence of tumor 
relapse), and inert (i.e. not inflammatory, or 
eliciting an immune response) [22]. 
A variety of muscle flaps are generally readily 
available for rotation to cover most chest wall 
defects (including pectoralis, latissimus dorsi, and 
rectus abdominis flap). The choice of flap coverage 
is chosen based upon the location and size of the 
defect, the availability and condition of adjacent 
muscles, prior or possibly future radiation, and 
the overall condition of the patient [23]. 
We used muscle flaps in 2 cases; one was 
rotational pectoral muscle flab after excision and 
mesh reconstruction of large upper left chest wall 
fibromatosis. The other one was a female patient 
who had large right chest wall osteosarcoma 
repaired by proline mesh and reinforced by 
latissimus dorsi muscle flap. 
Other non-available options in our center were 
bovine pericardial patch, titanium meshes, and 
titanium bars. Regarding complications 
encountered in the current study, bleeding was 
encountered in 5 cases (11.6%) with only one case 
of re-exploration, while superficial wound 
infection occurred in 9.3% of cases. Pulmonary 
complications included pneumonia (2.3%) and 
atelectasis (11.6%). Furthermore, chest wall 
instability was present in 11.6% of cases. Surgical 
mortality was not encountered in our cases.  
Any thoracic surgeon must put in mind that 
postoperative bleeding will be a dilemma after 
chest wall reconstruction. Hence perfect 
hemostasis is a must. 
The reported chest wall reconstruction-
related complications range from 24 to 46 
percent in large reviews [24-26]. Multiple studies 
have reported that mortality following chest wall 
reconstruction is most commonly related to 
pulmonary complications and sepsis with rates 
ranging from zero to 17% [27-31].  
In another study [30] which included 7 cases, 
two early complications, and one late 
complication (asymptomatic bone allograft 
fracture on the site of the bar implant) were 
encountered.  
A recent retrospective single-center study 
performed by Osman and his colleagues 
published in this journal [31] that concluded all 
patients who underwent chest wall 
reconstruction for a variety of defects resulting 
from resection of tumors, 
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trauma due to primarily firearms or motor car 
accidents, resection of radio necrotic tissues, 
infection and dehiscence of median sternotomy 
wounds after cardiac surgery. The study was 
conducted in a university hospital in the southern 
part of our country.  
Their study comprised 30 patients (70% males) 
in 3 and half years duration, with a median age of 
43 ± 16.3 years, resection and reconstruction were 
performed in 23 cases (15 neoplastic,5 infective 
and 3 firearm cases) while reconstruction alone 
was performed in 7 (traumatic flail chest) cases. 
Eighteen patients, underwent rib resection with 
an average of 4.18 ± 2.2 ribs (range 2-6). 
Associated lung resection was performed in 5 
patients (27.8 %): diaphragmatic resection was 
done in 2 cases also total sternal resection was 
performed in 5 cases.   
Only 15 patients were operated for chest wall 
neoplasms. Reported pathologies were 7 
Chondrosarcomas, 2 osteogenic sarcomas, 2 
round cell malignancies, 2 sternal liposarcomas, 1 
rhabdomyosarcoma, and 1 mesothelioma 
invading the chest wall.  
Unlike our study, the number of cases was less 
than half the number of our presented study, the 
distribution of the pathologies was different. Our 
age group was significantly younger than that in 
their study population. Recurrence was reported 
in one case of round cell tumors due to non-
compliance with chemo-radiotherapy.   
Osman and his colleagues [31] commonly 
used prolene mesh (43%), methyl methacrylate 
(13.3%), Muscle flaps (10%), Omental patches 
(10%), plates and screws (13.3%), and stainless-
steel wires for chest wall reconstruction. Yet, no 
specific detail was brought as regards the 
reconstructing the defects for chest wall 
neoplasm cases. Gonfiotti, et al. [6] reported a 
local recurrence for a desmoid tumor and a high-
grade sarcoma 15 and 26 months postoperative 
respectively. 
On our follow up, recurrence was diagnosed in 
9.3% of cases (n = 4), two of them had fibromatosis 
and responded well to adjuvant therapy (one of 
them had a positive resection margin and recurred 
9 months later and the other was 12 months 
postoperative). The other two recurrences were 
chondrosarcoma 6 months postoperative (had a 
negative margin) and recurrent metastatic chest 
wall mass secondary to a cancer breast that was 
operated 10 months before. No postoperative 
deaths were registered during our minimum of 13-
month follow up period. No further events were 
recorded in cases followed up to three years 
postoperatively (Figure 3).  
It has been previously reported that 
recurrence rates vary as per the tumor pathology 
as well as response to chemothoereapy [14]. 
Bony malignant chest wall tumors account for 
55% of all chest wall masses and have an average 
5-year survival of 60%. In chondrosarcomas, 10% 
of patients with negative margins will have local 
recurrence; whereas 75% of those with positive 
margins will have local recurrence. Malignant 
fibrous histiocytomas (MFHs) have a reported 
local recurrence rates of higher than 30%. 
Liposarcoma have high recurrence rates due to 
little response to chemo-radiotherapy [14].  
Study limitations 
This study is a single-center study prospective 
performed in a high-volume center for 5 years. 
Data from multiple centers with a larger number 
of cases and a wider variety of pathologies can be 
included in a larger study. More extensive use of 
video-assisted thoracoscopic surgery for excision 
of chest wall tumors should be used in our center. 
Titanium plates and other materials for chest wall 
reconstruction were not used in this study. The 
study did not compare the mid-term outcomes of 
different reconstruction techniques for all cases. 
Postoperative lung function was not tested and 
was not compared to preoperative LFT as this 
outcome was out of the scope of this particular 
study. The study lacks mid-term and long term 
follow up results for some of the study 
participants. A long-term follow-up is required in 
cases with malignant chest wall neoplasm and 
Desmoid tumors due to high recurrence rates. 
Conclusion 
Surgical intervention is very effective if 
tailored to every patient. A spectrum of 
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reconstructive techniques for larger defects exists 
with comparable outcomes and costs. A 
multidisciplinary team approach is usually 
preferred especially if an extensive demolition is 
required. Indeed, radical wide en-bloc resection 
can achieve satisfactory results provided that the 
extent of resection is not influenced by any 
anticipated reconstruction problems. 
Reconstruction materials are either autologous or 
synthetic. Prolene mesh and methyl methacrylate 
sandwich technique remain reasonable and 
relatively cheap synthetic options 
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